A recent collaborative study has advanced the use of machine learning (ML) tools, demonstrating their potential to predict the risk of contamination linked with medical devices and to forecast the 30-day health outcomes for patients in the intensive care unit (ICU). The research leveraged data from 8574 ICU patients that underwent invasive procedures, extracted from the Medical Information Mart for Intensive Care (MIMIC-IV) version 2.2 database. Patients’ data was divided into training and validation sets in a 7:3 ratio. The prediction of device-associated infections relied on seven distinct ML models, while five separate models were employed to predict the 30-day survival outcomes.
The performance of each model was primarily analyzed using the receiver operating characteristic (ROC) curve for infection prediction and the model’s concordance index (C-index) for survival outcomes. The evaluation demonstrated that the extreme gradient boosting (XGBoost) and extra survival trees (EST) models worked exceptionally well irrespective of the number of variables incorporated.
Healthcare-associated infections (HAIs) like the device-related ones pose a significant risk for patients, contributing to 37,000 deaths per year in Europe and 99,000 in the U.S. This category includes ventilator-associated pneumonia (VAP), central line-associated bloodstream infections (CLABSIs), and catheter-associated urinary tract infections (CAUTIs). Accurate prevention of such infections reduces healthcare costs and improves patient outcomes.
Usually, infection prevention measures include primary education, continuous feedback, and surveillance. High efficacy of intervention practices has been demonstrated in previous studies. Moreover, the International Nosocomial Infection Control Consortium (INICC) network has proven effective in minimizing infection rates.
The traditional multivariate logistic analysis used for identifying risk factors and devising predictive models is limited by the dependency on a linearity assumption between risk factors and outcomes. On the other hand, ML neglects this assumption, offering the possibility of uncovering hidden patterns in complex datasets through algorithmic training.
ICU patients’ infection risk heightens with the number of invasive procedures they undergo, necessitating precise predictive models. The new study aimed to develop ML models predicting the risk of device-associated infections and 30-day survival outcomes in ICU patients post-invasion, with the models incorporated into a web-based application for the convenience of clinicians.
These advancements herald a new frontier in infection control, offering objective tools to assess the risk and guide the care pathways for ICU patients. However, the practical utility of these advanced models will require further validation in multiple settings, as well as continuous updates to ensure they stay relevant and reliable.